Aclaris Therapeutics, Inc. is a privately held specialty pharmaceutical company focused on the development of novel dermatological therapies.
Adagene is an innovative antibody engineering technology company in China.
Bikam Pharmaceuticals is a drug discovery company focused on developing novel therapies for diseases of the eye with exceptionally high unmet medical need. The initial focus of the company will be on treatments for retinitis pigmentosa, a rare and incurable genetic disease that leads to blindness.
Blueprint Medicines is driving the development of personalized, highly-selective cancer therapies that harness the growing understanding of the molecular blueprint of cancer. Using its powerful Insights-to-Validation™ Platform and proprietary chemical library, Blueprint Medicines is working to develop new therapeutic compounds and combination therapies that target the molecular aberrations that cause cancer and the emerging resistance mechanisms that make it increasingly difficult to treat.
CardioKine is a pharmaceutical company focused on the development of lixivaptan, an oral compound under development for the potential treatment of hyponatremia in patients with congestive heart failure.
EnVivo Pharmaceuticals is a biopharmaceutical company dedicated to discovering and developing therapeutics for disorders of the central nervous system (CNS).
FoldRx Pharmaceuticals focused on creating disease modifying drug therapies for diseases of protein misfolding. Their lead program, Tafamadis, a first-in-class therapy for amyloidosis, has successfully completed a pivotal trial. FoldRx was acquired by Pfizer in September 2010.
Hile is a leading animal vaccine manufacturer that specializes in sales, marketing and commercialization of animal vaccine products in China.
Hua Medicine is a pharmaceutical research and development company in China focused on discovering and developing clinically differentiated medicines for world-wide markets.
Innovent Biologics is a therapeutics developer and manufacturer focused on providing innovative biopharmaceutical products for growing unmet medical needs in China and other geographies.
Ikano Therapeutics is a specialty pharmaceutical company focused on developing nasally delivered pharmaceutical products for well-identified niche markets where rapid onset and nasal delivery provide medical and commercial advantages Ikano's lead asset, ITI-111 for seizure control, was transfered to Upsher-Smith Laboratories in June 2010 for undisclosed up-front, development and commercial milestones.
Imagen Biotech is focused on the development of breakthrough treatments for blinding diseases with high unmet medical needs, including dry age-related macular degeneration (dry AMD).
Ironwood Pharmaceuticals is a leading drug development company. Their lead product, linaclotide is a first-in-class therapy that has completed successful Phase III studies in both irritable bowel syndrome and chronic constipation.
Laurus Labs is an India-based company that develops a range of pharmaceutical bulk actives and intermediates in several therapeutic categories, principally in oncology and antiretrovirals (ARVs), and has more than 30 actives and intermediates in various stages of development.
LigoCyte Pharmaceuticals is a vaccine discovery and development company with a first-in-class vaccine for norovirus, a pathogen that is a leading cause of viral gastroenteritis (stomach flu). LigoCyte is also developing vaccines for respiratory syncytial virus (RSV)and influenza.
Mersana Therapeutics is a drug development company based on Fleximer, a proprietary product platform. Fleximer is a patent-protected polymer used to modify the safety and efficacy of injected drugs. The company's current focus is on using Fleximer to create and develop commercially-attractive
NeuroTherapeutics Pharma, Inc. (NTP) is a biopharmaceutical company focused on developing therapies for diseases associated with central nervous system hyper-excitability. The company is working with novel mechanisms that will generate first-in-class therapeutics, thereby changing the standard of care for patients
NextWave Pharmaceuticals is a specialty pharmaceutical company seeking to create and promote differentiated products in the pediatric market. NextWave's products include improved oral liquid formulations of generic FDA-approved drugs and nutritional supplements. NextWave has partnered with Tris
NovaMed Pharmaceuticals is a revenue-generating specialty pharmaceutical company focused on commercialization of branded innovative therapies for diseases with high unmet medical need in China, including oncology, urology, and cardiovascular.
Proteostasis Therapeutics is a drug discovery company focused on developing novel therapies for new therapeutics that control the body's natural protein homeostasis or "Proteostasis Network."
Respivert -Acquired by Centocor Ortho Biotech in 2010
Respivert is a drug discovery and development company focused on inhaled therapies for severe respiratory disease. The company was acquired by Centocor Ortho Biotech (a division of Johnson and Johnson) in May 2010.
Tetraphase Pharmaceuticals discovers and develops new tetracycline-class drugs leveraging a dynamic chemistry engine developed by Dr. Andrew Myers and exclusively licensed from Harvard. The first application of this technology is to develop new antibiotics to treat drug-resistant infections.
Topaz is a later-stage pediatric specialty pharmaceutical company developing a topical prescription product for the treatment of head lice. The company has developed a head lice treatment that is a novel formulation of an approved drug with a long history of safe use as an oral antiparasitic.
Transave is a pharmaceutical company whose mission is to improve the treatment of serious lung diseases through the company's next generation, proprietary liposomal delivery technology. The company's lead product, Arikace, successfully completed Phase II clinical trials for cystic fibrosis and bronchiectasis. Transave and Insmed Incorporated (NASDAQ: INSM) merged in December 2010.
Ultragenyx is a pharmaceutical company focused on the development of novel therapies for rare genetic disorders.
Vicept Therapeutics is an early-stage dermatology specialty pharmaceutical company developing a topical prescription product for the treatment of rosacea, a chronic skin condition characterized by persistent facial erythema (i.e., redness) and acne-like pustules, that affects nearly 14 million Americans aged 20-65. Vicept was acquired by Allergan in July 2011.
Wuxi Pharma Tech is a leading provider of R&D pharmaceutical services, specializing in chemistry research, from lead discovery, optimization, bioanalytical and biology services and development to commercial manufacturing.
Medical Devices and Tools
Accuri Cytometers is a life sciences tools company that has developed a novel instrument for the $1B+ flow cytometry market. The company was founded by a creative team with a mission to develop a more affordable flow cytometer. Accuri was acquired by Becton, Dickinson and Company in February 2011.
BetterLife Medical is a fully-integrated hearing aid manufacturer developing and commercializing novel digital programmable hearing aid solutions for the Chinese market.
Bioconnect Systems is a medical device company developing products for vascular and general surgeons. Its first product is the OptiFlow AV, a small polymer conduit for connecting an artery to a vein in order to form an arterio-venous (A/V) fistula for renal dialysis access.
BioRegen Biomedical is a fully integrated medical product company based on a proprietary technology platform. BioRegen is developing and commercializing high quality hyaluronic acid ("HA") based products for the Chinese market.
Fluidnet is a medical device company developing a next-generation infusion pump based on pneumatics rather than mechanics. Architecture, network-ability, and user interface will confer substantial benefits that address the growing workflow, connectivity, safety, and regulatory demands across most clinical areas of care.
MDDF is a leading medical device manufacturer in China focused on delivering cutting edge cardiovasular solutions to patients.
TCT Medical, Inc. - Acquired by Hologic in 2011
TCT Medical is a diagnostic company in China providing high quality diagnostic tests, primarily in the women's health arena. With an extensive and expanding direct national sales network and strong brand name in the Ob/Gyn clinical community, TCT is well positioned to become an attractive commercialization platform of
ViewRay is an early-stage medical device company focused on developing the Renaissance, an MRI-based image-guided radiation therapy device for cancer patients.
Xcyton is an India-based medical diagnostics company dedicated to providing certainty in diagnosis for critical care infections through its wide array of immunodiagnostic and molecular diagnostic services.
The Iora model of care changes everything - payment, staffing, processes, IT systems, and culture. We have no status quo to defend, no arcane rules we must follow. Our only goal is to dramatically improve the experience and quality of care for everyone.
Kyruus is a leading Big Data company that enables hospitals and health systems to take a data-driven approach to building, operating, and optimizing their physician networks. The first-in-class KyruusOne(TM) data mining and analytics platform creates a "unified view of the physician" across demographic, clinical, research, financial, and performance-related dimensions. Kyruus' purpose-built search, analysis, and workflow applications deliver measurable ROI in areas of network development, regulatory compliance, and referral network management by directly engaging physicians to help reduce their administrative overhead, optimize decision-making, and increase the efficiency of their clinical practice and research activities.
Liazon is a provider of web-based private benefits exchanges to small and medium-sized businesses in which employees are able to customize their personal benefits coverage from a bundle of pre-selected insurance plans (medical, dental, vision, etc.) and other benefits. Liazon’s web-based Bright Choices portal allows each employer to set a defined contribution amount for each employee to spend, while providing employees with robust tools and resources necessary to create a personalized, optimized portfolio of benefits.
Procured Health allows hospitals to tackle their fastest growing cost category - medical devices, by providing an unparalleled level of transparency to support purchasing decisions. Our web application helps hospitals discover, evaluate, and adopt high value medical devices.